These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14758329)

  • 1. Iron out the details of therapeutic phlebotomy.
    Parker DM; Deel PC; Arner SS
    Nursing; 2004 Feb; 34(2):46-7. PubMed ID: 14758329
    [No Abstract]   [Full Text] [Related]  

  • 2. Current applications of therapeutic phlebotomy.
    Assi TB; Baz E
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s75-83. PubMed ID: 24120605
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemochromatosis and porphyria.
    Lambrecht RW; Bonkovsky HL
    Semin Gastrointest Dis; 2002 Apr; 13(2):109-19. PubMed ID: 12064861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic haemochromatosis presenting as porphyria cutanea tarda.
    Syn WK; Ahmed MM
    Int J Clin Pract Suppl; 2005 Apr; (147):48-50. PubMed ID: 15875621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
    Evers D; Kerkhoffs JL; Van Egmond L; Schipperus MR; Wijermans PW
    J Clin Apher; 2014 Jun; 29(3):133-8. PubMed ID: 24130064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performing therapeutic venesection in a doctor's surgery.
    Hy L; Ho HW
    Aust Fam Physician; 2017 Mar; 46(3):132-138. PubMed ID: 28260267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload.
    Fargion S; Fracanzani AL; Romano R; Cappellini MD; Faré M; Mattioli M; Piperno A; Ronchi G; Fiorelli G
    J Hepatol; 1996 May; 24(5):564-9. PubMed ID: 8773911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porphyria cutanea tarda symptomatica (PCT-S). A study of the effect of phlebotomy therapy.
    Epstein JH; Redeker AG
    Arch Dermatol; 1965 Sep; 92(3):286-9; discussion 289-90. PubMed ID: 11851252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyria cutanea tarda with menopausal exacerbation: the possible role of menstruation as natural phlebotomy.
    Nishioka E; Funasaka Y; Bito T; Ito A; Tani M; Kawara A; Yoon S; Kondo M; Ichihashi M
    J Am Acad Dermatol; 2003 Sep; 49(3):547-50. PubMed ID: 12963930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of liver iron content by magnetic resonance imaging in 20 patients with overt porphyria cutanea tarda before phlebotomy therapy: a prospective study.
    Dereure O; Jumez N; Bessis D; Gallix B; Guillot B
    Acta Derm Venereol; 2008; 88(4):341-5. PubMed ID: 18709302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda: a case report.
    Usta Atmaca H; Akbas F
    J Med Case Rep; 2019 Jan; 13(1):17. PubMed ID: 30661508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C, hemochromatosis and porphyria cutanea tarda].
    Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U
    Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who needs a therapeutic phlebotomy?
    Antle EA
    Clin J Oncol Nurs; 2010 Dec; 14(6):694-6. PubMed ID: 21112847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria Cutanea Tarda Due to Primary Hemochromatosis.
    Larrondo J; Gosch M
    Am J Med; 2020 Nov; 133(11):e681-e682. PubMed ID: 32416179
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemochromatosis gene mutations and response to chloroquine in sporadic porphyria cutanea tarda.
    Toll A; Celis R; Ozalla MD; Ercilla MG; Herrero C
    Acta Derm Venereol; 2006; 86(3):279-80. PubMed ID: 16710604
    [No Abstract]   [Full Text] [Related]  

  • 16. New reasons for an archaic treatment: phlebotomy in sporadic porphyria cutanea tarda.
    Mascaro JM; Herrero C
    Arch Dermatol; 2003 Mar; 139(3):379-80. PubMed ID: 12622638
    [No Abstract]   [Full Text] [Related]  

  • 17. Beyond leeches. Therapeutic phlebotomy today.
    Wright SM; Finical J
    Am J Nurs; 2000 Jul; 100(7):55-9, 61, 63. PubMed ID: 10914071
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosis.
    Evers D; Kerkhoffs JL; Van Egmond L; Wijermans PW
    Transfus Apher Sci; 2013 Apr; 48(2):187. PubMed ID: 23809828
    [No Abstract]   [Full Text] [Related]  

  • 19. How do I…perform therapeutic phlebotomy?
    Peedin AR; Karp JK
    Transfusion; 2021 Mar; 61(3):673-677. PubMed ID: 33580971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review.
    Shieh S; Cohen JL; Lim HW
    J Am Acad Dermatol; 2000 Apr; 42(4):645-52. PubMed ID: 10727312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.